Decline in breast cancer incidence due to removal of promoter: combination estrogen plus progestin.
Colditz, Graham A
Decline in breast cancer incidence due to removal of promoter: combination estrogen plus progestin. [electronic resource] - Breast cancer research : BCR 2007 - 108 p. digital
Publication Type: Comment; Editorial; Research Support, Non-U.S. Gov't
1465-542X
10.1186/bcr1736 doi
Breast Neoplasms--epidemiology
Drug Therapy, Combination
Estrogen Replacement Therapy--adverse effects
Estrogens--adverse effects
Female
Humans
Progestins--adverse effects
Decline in breast cancer incidence due to removal of promoter: combination estrogen plus progestin. [electronic resource] - Breast cancer research : BCR 2007 - 108 p. digital
Publication Type: Comment; Editorial; Research Support, Non-U.S. Gov't
1465-542X
10.1186/bcr1736 doi
Breast Neoplasms--epidemiology
Drug Therapy, Combination
Estrogen Replacement Therapy--adverse effects
Estrogens--adverse effects
Female
Humans
Progestins--adverse effects